Literature DB >> 28743077

Characterization and quantitative analysis of phenolic derivatives in Longxuetongluo Capsule by HPLC-DAD-IT-TOF-MS.

Jing Sun1, Yuelin Song1, Hui Sun1, Wenjing Liu1, Yunfeng Zhang1, Jiao Zheng1, Qian Zhang1, Yunfang Zhao1, Wei Xiao2, Pengfei Tu3, Jun Li4.   

Abstract

Longxuetongluo Capsule (LTC), which is derived from the total phenolic extract of Chinese dragon's blood, has been proved to be safe as well as effective towards ischemic stroke. However, the effective material basis remains unclear. The present study thereby focused on the clarification of the qualitative and quantitative properties for the phenolic derivatives in LTC. Regarding homolog-focused chemical profiling, the mass fragmentation patterns of the primary subtypes of phenolic compounds such as homoisoflavanones, flavanes, chalcones, and flavonoid oligomers were summarized by assaying authentic references with hybrid ion trap time-of-flight mass spectrometry, and the chemical structures of 124 phenolic compounds, in total, were unambiguously or tentatively annotated in LTC by matching the accurate mass spectral profiles with the proposed mass cracking rules and those reference substances. Afterwards, simultaneous determination of 12 primary phenolic compounds was carried out in different batches of LTC using HPLC-DAD, after that the method was proved to be accurate, precise, and reproducible according to diverse method validation assays. The obtained findings are expected to be meaningful for clarifying the effective substances and quality assessment of LTC.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemical profiling; HPLC-DAD-IT-TOF-MS; Longxuetongluo Capsule; Phenolic compounds; Quality assessment

Mesh:

Substances:

Year:  2017        PMID: 28743077     DOI: 10.1016/j.jpba.2017.07.012

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Systems Pharmacology-Dissection of the Molecular Mechanisms of Dragon's Blood in Improving Ischemic Stroke Prognosis.

Authors:  Meng Jiang; Xing Su; Jianling Liu; Chunli Zheng; Xiaogang Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-17       Impact factor: 2.629

2.  Rapid Evaluation of Chemical Consistency of Artificially Induced and Natural Resina Draconis Using Ultra-Performance Liquid Chromatography Quadrupole-Time-of-Flight Mass Spectrometry-Based Chemical Profiling.

Authors:  Qianping Chen; Lili He; Changming Mo; Zhifeng Zhang; Hairong Long; Xiaoyu Gu; Ying Wei
Journal:  Molecules       Date:  2018-07-25       Impact factor: 4.411

Review 3.  Phytochemistry and Pharmacological Activities of Dracaena cinnabari Resin.

Authors:  Yahya S Al-Awthan; Omar Salem Bahattab
Journal:  Biomed Res Int       Date:  2021-07-22       Impact factor: 3.411

4.  Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms.

Authors:  Bo Pan; Jing Sun; Ziyu Liu; Lingxiao Wang; Huixia Huo; Yunfang Zhao; Pengfei Tu; Wei Xiao; Jiao Zheng; Jun Li
Journal:  J Adv Res       Date:  2021-02-09       Impact factor: 10.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.